CannaPharmaRX, Inc.
CPMD
$0.003
$0.000.00%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.36M | 1.13M | 820.10K | 338.00K | 25.80K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.36M | 1.13M | 820.10K | 338.00K | 25.80K |
| Cost of Revenue | 4.55M | 3.87M | 3.78M | 1.65M | 979.30K |
| Gross Profit | -3.19M | -2.74M | -2.96M | -1.31M | -953.50K |
| SG&A Expenses | 314.80K | 432.80K | 597.40K | -21.40K | 427.70K |
| Depreciation & Amortization | -87.30K | -23.10K | -100.00 | -8.90K | 67.70K |
| Other Operating Expenses | 51.00K | 51.00K | 51.00K | 100.00K | 100.00K |
| Total Operating Expenses | 4.83M | 4.33M | 4.43M | 1.72M | 1.57M |
| Operating Income | -3.47M | -3.20M | -3.61M | -1.38M | -1.55M |
| Income Before Tax | -5.66M | 1.12M | -9.91M | 1.38M | 627.30K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -5.66 | 1.12 | -9.91 | 1.38 | 0.63 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -5.66M | 1.12M | -9.91M | 1.38M | 627.30K |
| EBIT | -3.47M | -3.20M | -3.61M | -1.38M | -1.55M |
| EBITDA | -3.37M | -3.04M | -3.42M | -1.08M | -1.11M |
| EPS Basic | -0.01 | 0.00 | -0.03 | 0.00 | -0.01 |
| Normalized Basic EPS | -0.01 | 0.00 | -0.02 | -0.02 | -0.02 |
| EPS Diluted | -0.01 | 0.00 | -0.03 | 0.00 | -0.01 |
| Normalized Diluted EPS | -0.01 | 0.00 | -0.02 | -0.02 | -0.02 |
| Average Basic Shares Outstanding | 2.65B | 2.65B | 2.33B | 2.03B | 1.66B |
| Average Diluted Shares Outstanding | 2.65B | 2.65B | 2.33B | 2.03B | 1.66B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |